Literature DB >> 15343179

Survey of vitamin A supplementation for extremely-low-birth-weight infants: is clinical practice consistent with the evidence?

Namasivayam Ambalavanan1, Kathleen Kennedy, Jon Tyson, Waldemar A Carlo.   

Abstract

OBJECTIVE: To survey the attitudes and practices among level III neonatal intensive care units in the United States regarding vitamin A supplementation for extremely-low-birth-weight (ELBW; birth weight < or =1000 g) infants. Study design A pretested questionnaire regarding vitamin A supplementation was distributed to all (n=102) neonatal-perinatal training program directors (TPD) and 105 randomly selected directors of level III neonatal intensive care units (nontraining program directors, NTPD).
RESULTS: Ninety-nine percent of TPD and 94% of NTPD responded. In a minority of programs (20% TPD, 13% NTPD), >90% of eligible extremely-low-birth-weight neonates are supplemented with vitamin A, whereas in most programs (69% TPD, 82% NTPD), routine supplementation is not practiced. Most centers (91% TPD, 81% NTPD) supplementing vitamin A use a dose of 5000 IU IM 3 times per week for 4 weeks. The most common reason that TPD give for not supplementing vitamin A is the perceived small benefit, whereas the most common reason for NTPD is that they consider the intervention unproven.
CONCLUSIONS: These findings indicate inconsistency in practicing evidence-based medicine in neonatal practice, where therapies are often administered on the basis of weaker evidence of safety and benefit than supports vitamin A supplementation. Educational interventions may be required to endorse the benefits and safety of vitamin A supplementation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15343179     DOI: 10.1016/j.jpeds.2004.04.046

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  10 in total

Review 1.  Vitamin A and preterm infants: what we know, what we don't know, and what we need to know.

Authors:  H Mactier; L T Weaver
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

2.  Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.

Authors:  Monika M Gadhia; Gary R Cutter; Steven H Abman; John P Kinsella
Journal:  J Pediatr       Date:  2013-12-31       Impact factor: 4.406

3.  Vitamin A supplementation in extremely low-birth-weight infants: subgroup analysis in small-for-gestational-age infants.

Authors:  Vedang A Londhe; Tracy L Nolen; Abhik Das; Rosemary D Higgins; Jon E Tyson; William Oh; Sherin U Devaskar
Journal:  Am J Perinatol       Date:  2013-01-17       Impact factor: 1.862

4.  Intramuscular Followed by Oral Vitamin A Supplementation in Neonates with Birth Weight from 750 to 1250 g: A Randomized Controlled Trial.

Authors:  S Giridhar; Jogender Kumar; Savita Verma Attri; Sourabh Dutta; Praveen Kumar
Journal:  Indian J Clin Biochem       Date:  2019-01-03

5.  Variations and similarities in clinical management of neonatal abstinence syndrome: Findings of a Canadian survey.

Authors:  Katie Murphy; Helen Coo; Ruth Warre; Vibhuti Shah; Kimberly Dow
Journal:  Paediatr Child Health       Date:  2017-05-15       Impact factor: 2.253

6.  Should Vitamin A Injections to Prevent Bronchopulmonary Dysplasia or Death Be Reserved for High-Risk Infants? Reanalysis of the National Institute of Child Health and Human Development Neonatal Research Network Randomized Trial.

Authors:  Matthew A Rysavy; Lei Li; Jon E Tyson; Erik A Jensen; Abhik Das; Namasivayam Ambalavanan; Matthew M Laughon; Rachel G Greenberg; Ravi M Patel; Claudia Pedroza; Edward F Bell
Journal:  J Pediatr       Date:  2021-05-15       Impact factor: 6.314

Review 7.  The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.

Authors:  Jennifer J P Collins; Dick Tibboel; Ismé M de Kleer; Irwin K M Reiss; Robbert J Rottier
Journal:  Front Med (Lausanne)       Date:  2017-05-22

8.  EARLY VITAMIN A SUPPLEMENTATION IMPROVES THE OUTCOME OF RETINOPATHY OF PREMATURITY IN EXTREMELY PRETERM INFANTS.

Authors:  Huiqing Sun; Rui Cheng; Zhansheng Wang
Journal:  Retina       Date:  2020-06       Impact factor: 3.975

9.  Surface activity of surfactant spiked with vitamin A.

Authors:  Vadim Bronshtein; Vugranam Venkatesh; Jas Aulakh; Philippe Chessex
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

10.  Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.

Authors:  Abhijeet Rakshasbhuvankar; Sanjay Patole; Karen Simmer; J Jane Pillow
Journal:  BMC Pediatr       Date:  2017-12-16       Impact factor: 2.125

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.